News|Articles|January 20, 2026

State of the Bio/Pharma Workforce: A Comparative Analysis of Employment Trends and Industry Sentiment

A comparison of 2024 and 2025 bio/pharma employment survey results indicates that industry professionals face eroding security, polarized satisfaction, and rising attrition risk.

This report provides a deep, comparative analysis of the bio/pharma employment landscape, offering critical insights into the evolving sentiment and stability of its workforce. Drawing on data from our 2024 Employment and Trends Survey (2024 Survey)—conducted during Q4 2024—and our 2025 Employment and Trends Survey (2025 Survey)—conducted in Q4 2025—this analysis dissects key trends across compensation, job security, employee satisfaction, workforce mobility, and industry outlook. By comparing these two periods, the report aims to construct a comprehensive and nuanced picture of the sector's human capital dynamics, identifying significant shifts in employee priorities and perceptions. This examination begins with one of the most fundamental aspects of the employer–employee relationship: financial compensation.

Report continues below infographic.